Sign up to save your podcasts
Or
Share FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
In this episode, Dr. David J. Schneider research identifies platelet FCγRIIA (PFCG) as a key biomarker for cardiovascular risk post-myocardial infarction. In an 800-patient study, higher PFCG levels were linked to increased risks of myocardial infarction, stroke, and death, indicating its potential for guiding personalized antiplatelet therapy, pending further validation.
View all episodes
By American College of Cardiology
4.2
154154 ratings
In this episode, Dr. David J. Schneider research identifies platelet FCγRIIA (PFCG) as a key biomarker for cardiovascular risk post-myocardial infarction. In an 800-patient study, higher PFCG levels were linked to increased risks of myocardial infarction, stroke, and death, indicating its potential for guiding personalized antiplatelet therapy, pending further validation.
More shows like JACC This Week
View all
JAMA Editors' Summary
131 Listeners
NEJM This Week
325 Listeners
This Week in Cardiology
864 Listeners
JAMA Clinical Reviews
496 Listeners
JACC Specialty Journals
22 Listeners
Circulation on the Run
31 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
JAMA Medical News
90 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
138 Listeners
Core IM | Internal Medicine Podcast
1,095 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
61 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
185 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners